Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Grants Priory Review for Human Monoclonal Antibody Drug to Treat Muscle-Invasive Bladder Cancer - 20 days ago Antibody Drug Conjugate Targeting CLDN1 Receives FDA Fast Track Designation - about 1 month ago FDA Panel Endorses Donanemab to Treat Early-Stage Alzheimer Disease - 7 months ago
2	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Modified Donanemab Dosing May Reduce ARIA-E Risk in Early Alzheimer's - 22 days ago Inebilizumab for Myasthenia Gravis Reduces Steroid Burden - about 2 months ago Sequencing in Advanced Urothelial Carcinoma - about 2 months ago Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 6 months ago Dupilumab Reduces Airway Inflammation, Mucus Plugs in Asthma Patients - 9 months ago Dato-DXd More Effective, Tolerable Than Chemo for Metastatic Breast Cancer - 12 months ago 'Exploding' Field of Antibody-Drug Conjugates Makes Inroads in Ovarian Cancer - about 1 year ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - about 1 year ago Tralokinumab Controls Moderate-to-Severe AD Over the Long Term - about 1 year ago IL-13 Blocker for Eczema Maintains Efficacy at Less-Frequent Dosing - about 1 year ago The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer - about 1 year ago
3	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Alzheimer's Data Withdrawn - about 1 month ago Novel Agent Reduces Monthly Migraine Days - 4 months ago Why Alzheimer's Drug Approval Delay? $3 Billion in DMD Gene Therapy; ADHD Prevalence - 9 months ago Opening Blood-Brain Barrier to Deliver Alzheimer's Drug Shows Promise - 12 months ago Alzheimer's Vaccines Are Back; Streamlining Prior Authorization; Rare APOE Variant - about 1 year ago Subcutaneous Alzheimer's Drug May Be on the Horizon - about 1 year ago
4	Kristen Monaco MedPage Today	Complement Inhibitor Shows Promise for Rare Kidney Disorder - about 2 months ago Investigational Once-Monthly Injectable Boosts Response Rate in Acromegaly - 5 months ago
5	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Another Win for Antibody-Drug Conjugate in HER2+ Breast Cancer With Brain Mets - 3 months ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 4 months ago First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response - about 1 year ago First Treatment Approved for Genetic Clotting Disorder - about 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - about 1 year ago
6	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Lebrikizumab Wins FDA Approval for Eczema - 3 months ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 3 months ago FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma - 6 months ago FDA Accepts sBLA for Bimekizumab-bkzx in Hidradenitis Suppurativa Treatment - 9 months ago FDA Approves Tocilizumab-aazg as Biosimilar to Actemra for Multiple Indications - 10 months ago Results Show Dupilumab Reduces Airway Inflammation In Asthma - 10 months ago FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 10 months ago FDA Approves Adalimumab-ryvk as Interchangeable Biosimilar for Humira - 10 months ago Biosimilar Adalimumab, Etanercept Have Equivalent Effectiveness to Reference Drugs Over 48 Months - 11 months ago Biogen Reprioritizes Alzheimer Disease Franchise, Discontinuing Aducanumab and Advancing Lecanemab - 11 months ago Study: Biosimilarities Found Between Yusimry and Humira for Immune, Rheumatic Conditions - 12 months ago FDA Approves Enfortumab Vedotin, Pembrolizumab for Treatment of Urothelial Cancer - about 1 year ago FDA Accepts Supplemental Biologics License Application for Hadlima for Interchangeability With Humira - about 1 year ago Subcutaneous Lecanemab Demonstrates Greater Amyloid Plaque Removal Than Intravenous Lecanemab - about 1 year ago
8	Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	Upadacitinib Can Significantly Improve Clinical Outcomes in Patients With Atopic Dermatitis - 10 months ago FDA Questions Donanemab Efficacy for the Treatment of Alzheimer Disease - 10 months ago FDA Accepts BLA for Datopotamab Deruxtecan for the Treatment of NSCLC - 10 months ago
9	Pharmaceutical Executive Editorial Staff Pharmaceutical Executive Pharma Executive Magazine. London & New Jersey PharmaceuticalsHealthcare	FDA Fast Tracks Candel Therapeutics' Novel Treatment for Pancreatic Ductal Adenocarcinoma - 12 months ago FDA Accepts Biologics License Application for CSL Behring’s Garadacimab for Hereditary Angioedema - about 1 year ago FDA Approves Expanded Indication for LEO Pharma's Adbry for Pediatric Patients With Atopic Dermatitis - about 1 year ago FDA Accepts sBLA for Interchangeability Designation for Latest Humira Biosimilar - about 1 year ago FDA Approves Takeda's Treatment for Rare Blood Clotting Disorder - about 1 year ago FDA Approves Cosentyx as Treatment Option for Hidradenitis Suppurativa - about 1 year ago
10	Wayne Kuznar MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Study Supports ADC as a New Option for Endocrine-Resistant Metastatic Breast Cancer - about 1 year ago

Journalists covering aducanumab